Table 2 Comparison of the distribution of BPA and phthalate metabolite levels in maternal blood of the three groups
Exposure | MDL (ng/ml) | Detection rate (%) | Normal (n = 245) | Borderline (n = 125) | Clinical (n = 88) | p value* | |||
|---|---|---|---|---|---|---|---|---|---|
Median | IQR | Median | IQR | Median | IQR | ||||
BPA | 0.011 | 94.0 | 0.054 | 0.022, 0.207 | 0.074 | 0.027, 0.370 | 0.097 | 0.037, 0.320 | 0.049 |
MnBP | 0.57 | 100.0 | 26.7 | 17.7, 37.6 | 25.1 | 16.8, 34.0 | 24.0 | 17.0, 35.0 | 0.221 |
MiBP | 0.44 | 100.0 | 7.4 | 5.3, 9.9 | 6.6 | 4.7, 8..7 | 7.2 | 5.3, 9.1 | 0.166 |
MBzP | 0.19 | 9.1 | <MDL | <MDL, <MDL | <MDL | <MDL, <MDL | <MDL | <MDL, <MDL | N/A |
MEHP | 0.31 | 96.5 | 1.42 | 0.82, 9.07 | 1.25 | 0.78, 8.20 | 1.53 | 067, 10.00 | 0.644 |
MEHHP | 0.23 | 0.7 | <MDL | <MDL, <MDL | <MDL | <MDL, <MDL | <MDL | <MDL, <MDL | N/A |
MECPP | 0.11 | 82.1 | 0.20 | 0.11, 0.30 | 0.21 | 0.11, 0.32 | 0.21 | 0.13, 0.34 | 0.470 |
cx-MiNP | 0.12 | 0.4 | <MDL | <MDL, <MDL | <MDL | <MDL, <MDL | <MDL | <MDL, <MDL | N/A |